Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Xie

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of the American College of Surgeons|December 8, 2025
Factors Associated with Receiving Thyroid Cancer Care from High-Volume Surgeons: Analysis of a Statewide Claims RegistryCatherine B Jensen, Charlotte Mk Jackson, Steven Xie, et al.
Journal of Medicinal Chemistry|February 21, 2026
Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1-S-Checkpoint-Compromised CancersJustin A Shapiro, Nathan J Dupper, Breena Fraga-Walton, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of the American College of Surgeons|December 8, 2025
Factors Associated with Receiving Thyroid Cancer Care from High-Volume Surgeons: Analysis of a Statewide Claims RegistryCatherine B Jensen, Charlotte Mk Jackson, Steven Xie, et al.
Journal of Medicinal Chemistry|February 21, 2026
Orally Bioavailable Cyclin A/B RxL Inhibitors: Optimization of a Novel Class of Macrocyclic Peptides That Target E2F-High and G1-S-Checkpoint-Compromised CancersJustin A Shapiro, Nathan J Dupper, Breena Fraga-Walton, et al.
Pageof 2